Skip to main content
. 2018 Aug;30(4):449–459. doi: 10.21147/j.issn.1000-9604.2018.04.08

1-1.

Table 1 (continued)
Variables Development set (N=684) Validation set (N=62) P
n % n %
CEA, carcinoembryonic antigen; *, standard of the ascites grading was as followed: Grade 0, no ascites; Grade 1, mild, only visible on ultrasound and CT; Grade 2, detectable with flank bulging and shifting dullness; Grade 3, directly visible, confirmed with the fluid wave/thrill test; **, standard of the performance status was as followed: 0, asymptomatic (fully active, able to carry on all pre-disease activities without restriction); 1, symptomatic but completely ambulatory; 2, symptomatic, <50% in bed during the day; 3, symptomatic, >50% in bed, but not bedbound; 4, bedbound (completely disabled, cannot carry on any self-care); ***, only 344 patients received palliative gastrectomy, including 296 in the Cancer Center of Sun Yat-sen University and 48 in the Sixth Affiliated Hospital of Sun Yat-sen University.
Pathological N staging*** 0.382
 N1 7 2.4 0 0
 N2 152 51.4 22 45.8
 N3a/b 137 46.3 26 54.2
Palliative chemotherapy 0.030
 Yes 483 70.6 35 56.5
 No 201 29.4 27 43.5